StockData

Cocrystal Pharma vs NanoViricides

COCP and NNVC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How COCP and NNVC compare

NanoViricides is the larger company, worth 1.5 times as much as Cocrystal Pharma ($29.6M against $19.5M).

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCOCPNNVC
Size and price
Market cap$19.5M$29.6M
Share price$1.01$1.16
Change, 1 year−1.9%−18.3%
Change, 5 years−91.3%−76.1%
Beta (5Y)2.421.91
Employees107
StockData Score
Total score55
Valuation score00
Growth score00
Performance score00
Health score55
Dividend score00
Valuation
P/B18.6×3.4× (better)
FCF yield–−26.3%
Profitability
Return on equity−312%−101% (better)
Return on invested capital–−111%
Financial health
Debt / equity0.000.00
Current ratio1.242.66 (better)
Altman Z-score−108.49−10.00 (better)
Piotroski F-score23 (better)
Dividends and buybacks
Buyback yield–−6.4%
Shareholder yield0.00% (better)−6.4%
Ownership
Held by institutions5.8%9.3%
Held by insiders60.3%0.00%
Insider net buying, 12 months$278K–
Short interest, % of float2.4%3.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.